US OptionsDetailed Quotes

CNM241220P52500

Watchlist

7.50
0.000.00%

15min DelayClose Nov 26 16:00 ET

0.00High0.00Low

Core & Main Stock Discussion

Moomoo AI

Mar 22 07:00

Core & Main's high P/E ratio is due to investors' anticipation of robust future growth. The company's excellent earnings outlook is driving its high P/E. Investors believe the risk of earnings decline isn't significant enough to warrant a lower P/E ratio.

Why Investors Shouldn't Be Surprised By Core & Main, Inc.'s (NYSE:CNM) 29% Share Price Surge

trailerparkolympics

Mar 18 06:15

$Core & Main (CNM.US)$

Core & Main(CNM) Pre-Mkt Price 51.400 +0.94%

Moomoo AI

Jan 30 15:25

Core & Main's acquisition of Dana Kepner is seen as a chance to broaden its geographic reach, diversify its product and service offerings, and incorporate key talent. The merger is expected to provide the water and wastewater industry with unparalleled service.

Press Release: Core & Main Signs Agreement to Acquire Dana Kepner

Bull Market Watch

Dec 22, 2023 16:14

Buy This Stock For 2024 | Solid Value Stock For Big Gains!

$Core & Main (CNM.US)$

Buy This Stock For 2024 | Solid Value Stock For Big Gains!

From YouTube

Moomoo Breakfast US

Sep 21, 2022 07:17

Columns Today's Pre-Market Stock Movers: MU, UAL, GIS, SFIX and More

Gapping up
In reaction to earnings/guidance:
• $Coty Inc (COTY.US)$ +3.9%, $General Mills (GIS.US)$+2.6%
Other news:
• $Clene (CLNN.US)$ +5.3% (announces presentation of updated survival results from the Phase 2 RESCUE-ALS trial open-label extension)
• $Clearway Energy-C (CWEN.US)$ +2.5% (Provides operational update on El Segundo Energy Center)
• $Apartment Income (AIRC.US)$ +2.4% (provides operating update)
• $Alpine Immune (ALPN.US)$ +2.3% (...

Moomoo Breakfast US

Sep 16, 2022 07:31

Columns Today's Pre-Market Stock Movers: FDX, UBER, GE, NTLA and More

Gapping up
In reaction to earnings/guidance:
• $Bowlero (BOWL.US)$ +3.4%
Other news:
• $Intellia Therapeutics (NTLA.US)$ +10.8% (Interim Clinical Data for its Second Systemically Delivered Investigational CRISPR Candidate, NTLA-2002)
• $Gogo Inc (GOGO.US)$ +5% (Repurchases 1.5 million shares of common stock from BlackRock)
• $ADC Therapeutics (ADCT.US)$ +2.9% (ADC Therapeutics and Swedish Orphan Biovitrum AB (BIOVF) confirms positive CHM...

Moomoo Breakfast US

Sep 13, 2022 07:42

Columns Today's Pre-Market Stock Movers: ORCL, RENT, U, AKRO and More

Gapping up
In reaction to earnings/guidance:
• $Planet Labs PBC (PL.US)$ +11.3%, $Core & Main (CNM.US)$ +6.1%, $Regal Rexnord (RRX.US)$ +2% (reaffirms outlook), $Oracle (ORCL.US)$ +1.6%
Other news:
• $Akero Therapeutics (AKRO.US)$ +93.2% (reports Phase 2b HARMONY Study)
• $Akouos (AKUS.US)$ +10.3% (FDA clears IND application to initiate a Phase 1/2 first in human pediatric clinical trial of AK-OTOF)
• $Catalyst Pharmaceuticals (CPRX.US)$ +7.7...

Moomoo Breakfast US

Jun 14, 2022 07:28

Columns Today's pre-market stock movers: ORCL, CLR, NOK, GRPN and more

Gainers:
• $National Vision (EYE.US)$ +13.8% (appointed to join S&P SmallCap 600)
• $Braze (BRZE.US)$ +12.2% (In reaction to earnings/guidance)
• $Oracle (ORCL.US)$ +11.7% (In reaction to earnings/guidance)
• $TeraWulf (WULF.US)$ +7.5% (announced recent financing actions and near-term ramp of digital infrastructure)
• $Continental Resources (CLR.US)$ +7.5% (announces receipt of "take private" proposal from Hamm Family of $70/share)
•...

Moomoo Breakfast US

Mar 31, 2022 07:53

Columns Today's pre-market stock movers: CLVS, PATH, DARE and more

Gainers:
• $Clovis Oncology (CLVS.US)$ +40.6% (Rubraca significantly improves progression-free survival in first-line maintenance treatment in women with ovarian cancer regardless of their biomarker status in phase 3 athena-mono trial)
• $Dare Bioscience (DARE.US)$ +13.61% (Organon and Dar Bioscience have entered into an agreement whereby Organon will license global rights to XACIATO)
• $KULR Technology (KULR.US)$ +9.5% (secured a battery sa...

Analysts Notebook

Mar 31, 2022 05:39

Columns Top upgrades and downgrades on 3/31

Upgrades
• $Baker Hughes (BKR.US)$ : Wells Fargo Upgrades to Overweight from EqualWeight - PT $43
• $CDW Corp (CDW.US)$ : Morgan Stanley Upgrades to Overweight from Equalweight - PT $214 (from $201)
• $Core & Main (CNM.US)$ : Barclays Upgrades to Overweight from Equalweight - PT $34 (from $32)
• $Five Below (FIVE.US)$ : Citigroup Upgrades to Buy from Neutral - PT $205 (from $176)
• $Vector (VGR.US)$ : Barclays Uprages to Overweight from Equal Weight - PT $16 (from ...

No comment yet